Plumline Life Sciences announced on the 7th that it has obtained domestic product approval from the Animal and Plant Quarantine Agency for Renudoc ™ (PLS-D1000), an innovative new drug developed to improve declines in physical activity, metabolism, and immune function caused by aging in senior dogs.

https://news.mt.co.kr/mtview.php?no=2024100708594020